Enliven therapeutics to present at upcoming investor conferences

Boulder, colo., may 22, 2025 /prnewswire/ -- enliven therapeutics, inc. (enliven or the company) (nasdaq: elvn), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will present at the following investor conferences: td cowen's 6th annual oncology innovation summit: insights from asco & eha format: fireside chatdate: tuesday, may 27, 2025 time: 1:00 p.m.
ELVN Ratings Summary
ELVN Quant Ranking